|
| |
University of Bonnthe University of Bonn, one of the largest and most multifaceted institutions of higher education in Germany. On the following web pages, you'll learn about our history, our profile and our work - and about the excellent opportunities that the University of Bonn offers students, academics and anyone interested in research and lecturing. We see ourselves as an institution that is modern and yet rooted in tradition, a university that doesn't hide away in the ivory tower of academia
| Contact Details: |
| Sigmund-Freud-Str. 25 |
| Bonn |
| |
| D-53105 |
| Germany |
| Tel: | 49-(0)228-287-0 |
| Fax: | 49-(0)228-287-6834 |
| Email: | presse.info@uni-bonn.de |
| WWW: | www.uni-bonn.de/
|
| |
Recent Publications by University of Bonn: |  |
A systematic association mapping on chromosome 6q in bipolar affective disorder-evidence for the melanin-concentrating-hormone-receptor-2 gene as a risk factor for bipolar affective disorder.
Strong evidence of linkage between chromosomal region 6q16-q22 and bipolar... | 21st November, 2009
| Institute of Human Genetics, University of Bonn, Bonn, Germany.
| Am J Med Genet B Neuropsychiatr Genet. 2009 Nov 19.
DOI Direct Link |
Inappropriately high circulating and intrarenal angiotensin II levels during dietary salt loading exacerbate hypertension in Cyp1a1-Ren-2 transgenic rats.
OBJECTIVE: We evaluated the effects of salt restriction and of increasing... | 21st November, 2009
| aDepartment for Experimental Medicine, Institute for Clinical and
| J Hypertens. 2009 Nov 18.
DOI Direct Link |
Hamartin variants that are frequent in focal dysplasias and cortical tubers have reduced tuberin binding and aberrant subcellular distribution in vitro.
Focal cortical dysplasia type IIb is characterized by epilepsy-associated... | 18th November, 2009
| Department of Neuropathology, University of Bonn Medical Center,
| J Neuropathol Exp Neurol. 2009 Oct;68(10):1136-46.
DOI Direct Link |
[6S]-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type 677C-->T polymorphism of methylenetetrahydrofolate reductase.
Background and purpose: 5,10-Methylenetetrahydrofolate reductase (MTHFR)... | 18th November, 2009
| Department of Nutrition and Food Sciences, Human Nutrition II,
| Br J Pharmacol. 2009 Nov 16.
DOI Direct Link |
Impact of intimal pathogen burden in acute coronary syndromes-correlation with inflammation, thrombosis, and autoimmunity.
Background and purpose: 5,10-Methylenetetrahydrofolate reductase (MTHFR)... | 17th November, 2009
| Department of Internal Medicine II/Cardiology, University of Bonn, Bonn,
| Cardiovasc Pathol. 2009 Nov 13.
DOI Direct Link |
→View more University of Bonn research publications. |
Press Releases on University of Bonn:
|
 |
| YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG |
29th October, 2009 |
YM BioSciences Inc. |
MISSISSAUGA, ON, Oct. 29 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI; TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of
|
| deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia |
1st July, 2009 |
DeCODE Genetics Inc |
REYKJAVIK, Iceland, July 1 /PRNewswire-FirstCall/ -- The largest study of
the genetics of schizophrenia ever undertaken has revealed several new common
single-letter variants in the sequence of
|
| Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union |
28th April, 2009 |
|
S.MAMEDE DO CORONADO, Portugal and LONDON, April 28 /PRNewswire/ -- Bial-Portela & CA, S.A., (S. Mamede do Coronado, Portugal,
President & CEO Dr Luis Portela), and Eisai Europe Limited
|
| Leading HIV Experts Convene to Tackle the Challenge of Late Presentation in Europe |
31st March, 2009 |
|
LONDON, March 31 /PRNewswire/ -- Almost three decades after the discovery of HIV/AIDS, and despite big
medical advances, there are still a significant number of HIV-infected
persons who present late
|
| 338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment |
4th September, 2008 |
BioForm Medical, Inc. |
SAN MATEO, Calif., Sept. 4 /PRNewswire-FirstCall/ -- BioForm Medical, Inc.
(Nasdaq: BFRM) today announced that the pivotal clinical study of Polidocanol,
conducted in Germany by BioForm Medical
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 1197 individuals from University of Bonn using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 657 times since April 2007, the link to the organisation's website has been followed 122 times Recent Search Terms used to find this page: university of bonn pharmaceutical | programme in plant biotechnology 2009 uni Bonn | university of bonn department of anesthesia | University of Bonn Pharmaceutical Institute | Pharmaceutical Institute University of Bonn | university of bonn medical center | Bonn ophthalmology | University of Bonn Medical Center | bonn university ophthalmology department | Mailing address | . Search for more companies in Bonn Search for more companies in This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for University of Bonn |
